Site icon Impactiviti

Impactiviti Daily 061510 Top Pharma News

*****

TODAY’S NEWS:

Cheap drug could be a life-saver – A cheap drug that can stop bleeding in recently injured accident patients could potentially save the lives of tens of thousands worldwide, a new study says. Researchers studied the effects of tranexamic acid, or TXA, in more than 10,000 adult trauma patients in 40 countries who received the drug within 8 hours of being injured. They compared those patients’ outcomes to more than 10,000 accident victims who got a placebo treatment. The study was published online Tuesday in the medical journal Lancetmore

Pfizer ends development of one experimental RA drug from Trubion; keeps another one going.

Glaxo gets FDA OK for combo prostate treatment.

Human Genome Sciences: low expectations for Hepatitis C drug approval.

Judge to Abbott: Pay reps overtime.

RECOMMENDED

Social Media 101/201. Here at Impactiviti, we’re immersed in both social media and pharma. We’re happy to provide on-site workshops for our clients who need to bring sales/marketing/training/executive teams up to speed on Trends in Social Media.  Contact us (stevew at impactiviti dot com, or phone at 973-947-7429) for details.

PLUS

Fresh updates to the astonishingly helpful Dose of Digital Social Media (Pharma/Healthcare) Wiki. And, a little thought-provoking tidbit: The Red Pill or the Blue Pill?

JUST FOR FUN

Nature’s Patterns in Photography. Sheer eye candy.

———-

Subscribe to the Impactiviti blog via e-mail (which will bring you Impactiviti Daily – a brief of the day’s top pharma news)

Visit the Impactiviti Job Board

Sign up for the Impactiviti Connection twice-monthly e-newsletter (see sample)

*****

Exit mobile version